EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The PPAR-γ Agonist Pioglitazone Modulates Proliferation and Migration in HUVEC, HAOSMC and Human Arteriovenous Fistula-Derived Cells

Carmen Ciavarella iD, Ilenia Motta, Francesco Vasuri, Teresa Palumbo, Anthony Paul Lisi iD, Alice Costa iD, Annalisa Astolfi iD, Sabrina Valente iD, Piera Versura iD, Eugenio F Fornasiero iD, Raffaella Mauro, Mauro Gargiulo und 1 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24054424 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Carmen Ciavarella und 12 weiteren Autor:innen. Beteiligte Einrichtung: DIMEC-Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy. Hauptthemen laut MEDLINE: Arteriovenous Shunt, Surgical, Arteriovenous Fistula, Thiazolidinediones. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione Cassa di Risparmio di Imola.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The failure of arteriovenous fistulas (AVFs) following intimal hyperplasia (IH) increases morbidity and mortality rates in patients undergoing hemodialysis for chronic kidney disease. The peroxisome-proliferator associated receptor (PPAR-γ) may be a therapeutic target in IH regulation. In the present study, we investigated PPAR-γ expression and tested the effect of pioglitazone, a PPAR-γ agonist, in different cell types involved in IH. As cell models, we used Human Endothelial Umbilical Vein Cells (HUVEC), Human Aortic Smooth Muscle Cells (HAOSMC), and AVF cells (AVFCs) isolated from (i) normal veins collected at the first AVF establishment (T0), and (ii) failed AVF with IH (T1). PPAR-γ was downregulated in AVF T1 tissues and cells, in comparison to T0 group. HUVEC, HAOSMC, and AVFC (T0 and T1) proliferation and migration were analyzed after pioglitazone administration, alone or in combination with the PPAR-γ inhibitor, GW9662. Pioglitazone negatively regulated HUVEC and HAOSMC proliferation and migration. The effect was antagonized by GW9662. These data were confirmed in AVFCs T1, where pioglitazone induced PPAR-γ expression and downregulated the invasive genes SLUG, MMP-9, and VIMENTIN. In summary, PPAR-γ modulation may represent a promising strategy to reduce the AVF failure risk by modulating cell proliferation and migration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arteriovenous Shunt, SurgicalArteriovenous FistulaThiazolidinedionesHumansPioglitazonePPAR-gamma AgonistsUmbilical VeinsCell ProliferationPPAR gammaMyocytes, Smooth MuscleAnilides

Stichwörter der Autor:innen

HAOSMCHUVECPPAR-γarteriovenous fistula (AVF)intimal hyperplasia (IH)migrationpioglitazoneprimary arteriovenous fistula cell model (AVFCs)proliferation

Substanzen

PioglitazonePPAR-gamma AgonistsPPAR gammaThiazolidinediones2-chloro-5-nitrobenzanilideAnilides

Autor:innen und Institutionen

  • DIMEC-Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.
  • Center for Applied Biomedical Research (CRBA), University of Bologna, 40138 Bologna, Italy.
  • Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
  • Alma Mater Institute on Healthy Planet, University of Bologna, 40138 Bologna, Italy.
  • Department of Pharmacology & Physiology, Drexel University College of Medicine, 245 N. 15th Street, Philadelphia, PA 19102, USA.
  • Ophtalmology Unit, IRCSS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

ORCID-Profile: Carmen Ciavarella, Anthony Paul Lisi, Alice Costa, Annalisa Astolfi, Sabrina Valente, Piera Versura, Eugenio F Fornasiero, Gianandrea Pasquinelli

Förderung

  • Fondazione Cassa di Risparmio di Imola

Zitieren

APA

Ciavarella, C., Motta, I., Vasuri, F., Palumbo, T., Lisi, A. P., Costa, A., Astolfi, A., Valente, S., Versura, P., Fornasiero, E. F., Mauro, R., Gargiulo, M., & Pasquinelli, G. (2023). The PPAR-γ Agonist Pioglitazone Modulates Proliferation and Migration in HUVEC, HAOSMC and Human Arteriovenous Fistula-Derived Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24054424

Vancouver

Ciavarella C, Motta I, Vasuri F, Palumbo T, Lisi AP, Costa A, et al. The PPAR-γ Agonist Pioglitazone Modulates Proliferation and Migration in HUVEC, HAOSMC and Human Arteriovenous Fistula-Derived Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24054424

BibTeX
@article{Ciavarella2023,
  author = {Ciavarella, Carmen and Motta, Ilenia and Vasuri, Francesco and Palumbo, Teresa and Lisi, Anthony Paul and Costa, Alice and Astolfi, Annalisa and Valente, Sabrina and Versura, Piera and Fornasiero, Eugenio F and Mauro, Raffaella and Gargiulo, Mauro and Pasquinelli, Gianandrea},
  title = {The PPAR-γ Agonist Pioglitazone Modulates Proliferation and Migration in HUVEC, HAOSMC and Human Arteriovenous Fistula-Derived Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24054424}
}
Kostenlos starten →